These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro effects of Melaleuca alternifolia essential oil on growth and production of volatile sulphur compounds by oral bacteria. Graziano TS, Calil CM, Sartoratto A, Franco GC, Groppo FC, Cogo-Müller K. J Appl Oral Sci; 2016; 24(6):582-589. PubMed ID: 28076463 [Abstract] [Full Text] [Related]
6. In vitro volatile sulfur compound production of oral bacteria in different culture media. Quirynen M, Van Eldere J, Pauwels M, Bollen CM, van Steenberghe D. Quintessence Int; 1999 May; 30(5):351-6. PubMed ID: 10635291 [Abstract] [Full Text] [Related]
7. Volatile sulfide compounds and oral microorganisms on the inner surface of masks in individuals with halitosis during COVID-19 pandemic. Lee YH, Kim H, Heo DW, Ahn IS, Auh QS. Sci Rep; 2023 Feb 13; 13(1):2487. PubMed ID: 36781937 [Abstract] [Full Text] [Related]
8. Relationship between halitosis and periodontal disease - associated oral bacteria in tongue coatings. Amou T, Hinode D, Yoshioka M, Grenier D. Int J Dent Hyg; 2014 May 13; 12(2):145-51. PubMed ID: 23890391 [Abstract] [Full Text] [Related]
10. Reduction of bacterial volatile sulfur compound production by licoricidin and licorisoflavan A from licorice. Tanabe S, Desjardins J, Bergeron C, Gafner S, Villinski JR, Grenier D. J Breath Res; 2012 Mar 13; 6(1):016006. PubMed ID: 22368239 [Abstract] [Full Text] [Related]
11. Relationship between volatile sulphide compounds concentration and oral bacteria species detection in the elderly. Senpuku H, Tada A, Yamaga T, Hanada N, Miyazaki H. Int Dent J; 2004 Jun 13; 54(3):149-53. PubMed ID: 15218895 [Abstract] [Full Text] [Related]
12. The relationship between volatile sulfur compounds and major halitosis-inducing factors. Lee CH, Kho HS, Chung SC, Lee SW, Kim YK. J Periodontol; 2003 Jan 13; 74(1):32-7. PubMed ID: 12593593 [Abstract] [Full Text] [Related]
15. The relationship between oral malodor and volatile sulfur compound-producing bacteria. Krespi YP, Shrime MG, Kacker A. Otolaryngol Head Neck Surg; 2006 Nov 13; 135(5):671-6. PubMed ID: 17071291 [Abstract] [Full Text] [Related]
16. Photodynamic therapy as a novel treatment for halitosis in adolescents: study protocol for a randomized controlled trial. Lopes RG, de Godoy CH, Deana AM, de Santi ME, Prates RA, França CM, Fernandes KP, Mesquita-Ferrari RA, Bussadori SK. Trials; 2014 Nov 14; 15():443. PubMed ID: 25394474 [Abstract] [Full Text] [Related]
17. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum. Liu PF, Huang IF, Shu CW, Huang CM. Curr Mol Med; 2013 Sep 14; 13(8):1358-67. PubMed ID: 23865430 [Abstract] [Full Text] [Related]
18. Prediction of periodontopathic bacteria in dental plaque of periodontal healthy subjects by measurement of volatile sulfur compounds in mouth air. Kishi M, Ohara-Nemoto Y, Takahashi M, Kishi K, Kimura S, Aizawa F, Yonemitsu M. Arch Oral Biol; 2013 Mar 14; 58(3):324-30. PubMed ID: 23107050 [Abstract] [Full Text] [Related]